← Back to the brief
Original source ↗
istitlaa (ISTITL) · Public Consultation
Saudi Food and Drug Authority: Regulatory Guidance for the Integration of New Approach Methodologies (NAMs) and Artificial Intelligence (AI) in Preclinical Submissions
الهيئة العامة للغذاء والدواء: دليل استخدام الطرق الحديثة والذكاء الاصطناعي في الدراسات ما قبل السريرية
Action required (deferred)Reference
This guidance aims to establish a standardized approach to integrating NAMs and AI into preclinical drug development, fostering innovation while ensuring adherence to safety standards.
PublishedNovember 5, 2026
Consultation closesDecember 4, 2026
GazetteNot gazetted
Saudi regulatory updates, in one morning brief
Bawadir tracks what Saudi regulators issue and delivers what needs your attention each working morning. Your email is all we ask for.
Free. One click to unsubscribe, any time.